[
    [
        {
            "time": "2019-10-31",
            "original_text": "【国盛医药张金洋团队】丽珠集团：扣非增速超预期，关注高质量增长&结构调整——2019三季报点评",
            "features": {
                "keywords": [
                    "丽珠集团",
                    "扣非增速",
                    "高质量增长",
                    "结构调整",
                    "三季报"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【国盛医药张金洋团队】丽珠集团：扣非增速超预期，关注高质量增长&结构调整——2019三季报点评",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2019-11-05",
            "original_text": "【平安医药】新版医保延续腾笼换鸟思路，纳入品种迎放量机会",
            "features": {
                "keywords": [
                    "新版医保",
                    "腾笼换鸟",
                    "纳入品种",
                    "放量机会"
                ],
                "sentiment_score": 0.75,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【平安医药】新版医保延续腾笼换鸟思路，纳入品种迎放量机会",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-08-30",
            "original_text": "【民生医药|中报总结】医药板块2019中报总结：增长的韧劲足，逐步加仓二线龙头",
            "features": {
                "keywords": [
                    "医药板块",
                    "中报总结",
                    "增长韧劲",
                    "加仓二线龙头"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【民生医药|中报总结】医药板块2019中报总结：增长的韧劲足，逐步加仓二线龙头",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        }
    ]
]